Martin Silverstein
Mana joins the hectic fight against solid tumors with an ‘off-the-shelf’ candidate angling for an IND this year
The hunt for effective therapies for solid tumors has heated up in early 2021 with a string of biotechs touting big investor checks and name …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
